Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.54 |
| ▸ | USP2 | O75604 | 2/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | CASP1 | P29466 | 1/20 | 0.54 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.54 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | RARB | P10826 | 7/20 | 0.48 |
| ▸ | RARA | P10276 | 2/20 | 0.48 |
| ▸ | RARG | P13631 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | MTOR | P42345 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4083443 | 0.98 | MEN1 (0.52) | MEN1ALDH1A1KMT2AUSP2SMN1; SMN2 | |
| SCHEMBL2790052 | 0.98 | MEN1 (0.52) | MEN1ALDH1A1KMT2AUSP2SMN1; SMN2 | |
| SCHEMBL31069791 | 0.98 | MEN1 (0.52) | MEN1ALDH1A1KMT2AUSP2SMN1; SMN2 | |
| SCHEMBL12972528 | 0.92 | MEN1 (0.56) | MEN1ALDH1A1KMT2AUSP2SMN1; SMN2 | |
| SCHEMBL6853512 | 0.87 | RARB (0.58) | CYP3A4TSHRRARB | |
| SCHEMBL6288257 | 0.87 | MEN1 (0.55) | MEN1ALDH1A1KMT2AUSP2SMN1; SMN2 | |
| SCHEMBL6851556 | 0.87 | RARB (0.58) | CYP3A4TSHRRARB | |
| SCHEMBL6851493 | 0.87 | RARB (0.58) | CYP3A4TSHRRARB | |
| SCHEMBL6853043 | 0.87 | RARB (0.58) | CYP3A4TSHRRARB | |
| SCHEMBL6292134 | 0.87 | PPARA (0.51) | MEN1ALDH1A1KMT2AUSP2SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7550181-B2 | Information recording medium | DAI NIPPON PRINTING CO., LTD. (JP) | 2009-06-23 | — | — | US | claimed |
| US-7709830-B2 | Organic semiconductor structure, manufacturing method of the same, and organic semiconductor device | DAI NIPPON PRINTING CO., LTD. (JP) | 2010-05-04 | — | — | US | disclosed |
| US-7638795-B2 | Organic semiconductor structure, process for producing the same, and organic semiconductor device | DAI NIPPON PRINTING CO., LTD. (JP) | 2009-12-29 | — | — | US | disclosed |
| US-7550181-B2 | Information recording medium | DAI NIPPON PRINTING CO., LTD. (JP) | 2009-06-23 | — | — | US | disclosed |
| US-20080188670-A1 | 1,4-Dithienylbenzene Derivative | NAT. INST. OF ADVANCED INDUSTRIAL SCI. AND TECH. (JP) | 2008-08-07 | — | — | US | disclosed |
| US-7399426-B2 | Liquid crystalline organic semiconductor material and organic semiconductor structure using the same | DAI NIPPON PRINTING CO., LTD. (JP) | 2008-07-15 | — | — | US | disclosed |
| US-7256064-B2 | Organic semiconductor device | DAI NIPPON PRINTING CO. LTD. (JP) | 2007-08-14 | — | — | US | disclosed |
| US-7256064-B2 | Organic semiconductor device | DAI NIPPON PRINTING CO. LTD. (JP) | 2007-08-14 | — | — | US | disclosed |
| US-20060113526-A1 | Organic semiconductor structure, manufacturing method of the same, and organic semiconductor device | DAI NIPPON PRINTING CO., LTD. (JP) | 2006-06-01 | — | — | US | disclosed |
| US-20060054883-A1 | Organic semiconductor device | DAI NIPPON PRINTING CO., LTD. (JP) | 2006-03-16 | — | — | US | disclosed |
| EP-1022732-B1 | Information recording medium | DAINIPPON PRINTING CO LTD (JP) | 2005-10-26 | — | — | EP | disclosed |
| US-20050224755-A1 | Liquid crystalline organic semiconductor material and organic semiconductor structure using the same | DAI NIPPON PRINTING CO., LTD. (JP) | 2005-10-13 | — | — | US | disclosed |
| US-20050025994-A1 | Organic electroluminescent element and method for producing the same | DAI NIPPON PRINTING CO., LTD. (JP) | 2005-02-03 | — | — | US | disclosed |
| US-6759749-B2 | Circuit structure, manufacturing method thereof and wiring structure | SHARP KABUSHIKI KAISHA (JP) | 2004-07-06 | — | — | US | disclosed |
| US-20040095517-A1 | Information recording medium | DAI NIPPON PRINTING CO., LTD. (JP) | 2004-05-20 | — | — | US | disclosed |
| US-6614501-B1 | Electroconductive device having supercooled liquid crystal layer | CANON KABUSHIKI KAISHA (JP) | 2003-09-02 | — | — | US | disclosed |
| US-20030129326-A1 | INFORMATION RECORDING MEDIUM | DAI NIPPON PRINTING CO., LTD. (JP) | 2003-07-10 | — | — | US | disclosed |
| US-20020145171-A1 | Circuit structure, manufacturing method thereof and wiring structure | SHARP KABUSHIKI KAISHA | 2002-10-10 | — | — | US | disclosed |
| EP-1022732-A1 | Information recording medium | DAI NIPPON PRINTING CO., LTD. (JP) | 2000-07-26 | — | — | EP | disclosed |
| JP-2000192042-A | DRIVING METHOD FOR LIQUID CRYSTAL ELEMENT | DAINIPPON PRINTING CO LTD | 2000-07-11 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080188670-A1 | 1,4-Dithienylbenzene Derivative | SLC22A4, SLC19A2, SLC22A1 | MEN1 639/4885ALDH1A1 890/4885KMT2A 1411/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.